The Emblematic Year of 2011, Trials and the 50 Years of Heart Transplantation: Three Relevant Issues
نویسندگان
چکیده
During the 25-year BJCVS celebrations in 2011, we had the first Impact Factor (IF) published by ISI-Thomson Reuters. The prime number of 0.963, almost 1, at first evaluation, shows the high degree of development of Brazilian cardiovascular surgery. In an attempt to check the SciELO database and verify if it coincides with the 25 years of the BJCVS, we observe the best academic performance of the BJCVS (Figure 1). It should be noted that this performance was independent of international collaboration (Figure 1B). This fact deserves careful evaluation to guide our editorial planning.
منابع مشابه
Recent Technological Advances in Hepatogenic Differentiation of Stem Cells Relevant to Treatment of Liver Diseases
Liver failure, in an acute or chronic form, is a growing health problem ranking as one of the leading causes of death worldwide. Inborn errors of metabolism characterized by defects in hepatic enzymes or other proteins with metabolic functions, such as receptors or transporters accompanied with environmental factors involve etiology and presentation of liver failure. Currently, the only establi...
متن کاملP-229: Uterine Transplantation, Is It A Promising Technique in Future?
Background: Uterine factor infertility (UFI) refers to the refractory causes of female infertility stemming from the anatomical or physiological inability of a uterus to sustain gestation. Today, uterine factor infertility affects 3-5% of the population. Traditionally, although surrogacy and adoption have been the only viable options for females affected by this condition, the uterine transplan...
متن کاملRole of Stem Cells in Cardiac Cell Therapy and Tissue Engineering
Background: In spite of promising results of conventional treatments for myocardial infarction, including medications, stent implantation, and coronary artery bypass grafting, the disease and its complications, especially heart failure, are highly prevalent because these methods could not reverse the cell loss, which is the main problem. Currently, heart transplantation, as the last option f...
متن کاملAre Stem Cells the next Therapeutic Tool for Heart Repair?
Cardiovascular disease remains the leading cause of morbidity and mortality in the United States and Europe. In recent years, the understanding that regenerative processes exist at the level of the myocardium, has placed stem cell research at center stage in cardiology. A stem cell is a cell that has the ability to divide (self replicate) for indefinite periods often throughout the life of the ...
متن کاملFive-Year Experience of Liver Transplant at Kerman University of Medical Sciences: Afzalipoor Hospital
Introduction: The only option for treatment of end stage liver diseases is liver transplantation. Afzalipour Hospital in Kerman, Iran is the third largest liver transplantation center in Iran. In this study, the outcomes of this center have been studied during the past 5 years. Methods: In this cross-sectional study, the pre and post transplantation’s clinical, demographic and outcome data of ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
دوره 32 شماره
صفحات -
تاریخ انتشار 2017